Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals - Trial NCT05062408
Access comprehensive clinical trial information for NCT05062408 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla and is currently Completed. The study focuses on Hepatitis C, Chronic. Target enrollment is 321 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Timeline & Enrollment
N/A
Mar 01, 2021
Apr 01, 2021
Primary Outcome
Number of patients with a progression of liver injury.
Summary
The purpose of this study is to evaluate the evolution of liver injury with fibrosis data
 obtained using non-invasive serological markers in patients who achieved SVR after treatment
 with direct-acting antivirals.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05062408
Non-Device Trial